A clinically relevant bi-cellular murine mammary tumor model as a useful tool for evaluating the effect of retinoic acid signaling on tumor progression
Autor: | María José Veloso, Elisa Bal de Kier Joffé, Eduardo F. Farias, Lydia Puricelli, Paola B. Campodónico, Laura B. Todaro |
---|---|
Rok vydání: | 2011 |
Předmět: |
Receptors
Retinoic Acid Cell Retinoic acid Ciencias de la Salud Fluorescent Antibody Technique Apoptosis Immunoenzyme Techniques chemistry.chemical_compound Mice Cell Movement Tumor Cells Cultured Pharmacology (medical) Retinoid Mammary tumor Mice Inbred BALB C Reverse Transcriptase Polymerase Chain Reaction General Medicine Cell cycle Flow Cytometry Otras Ciencias de la Salud medicine.anatomical_structure Oncology Female Signal Transduction medicine.medical_specialty CIENCIAS MÉDICAS Y DE LA SALUD medicine.drug_class Blotting Western Mitosis Mammary Neoplasms Animal Biology Adenocarcinoma Real-Time Polymerase Chain Reaction Retinoids BREAST CANCER Internal medicine medicine Cell Adhesion Animals Radiology Nuclear Medicine and imaging RNA Messenger Cell Proliferation Cell growth Epithelial Cells Urokinase-Type Plasminogen Activator Matrix Metalloproteinases LUMINAL AND MYOEPITHELIAL CELLS Disease Models Animal Endocrinology chemistry Cell culture Tumor progression METASTASIS Cancer research RETINOIDS |
Zdroj: | Breast cancer (Tokyo, Japan). 20(4) |
ISSN: | 1880-4233 |
Popis: | BACKGROUND: The effect of retinoic acid (RA) on breast cancer progression is controversial. Our objective was to obtain information about breast cancer progression, taking advantage of the ER-negative murine mammary adenocarcinoma model LM38 (LM38-LP constituted by luminal (LEP) and myoepithelial-like cells (MEP), LM38-HP mainly composed of spindle-shaped epithelial cells, and LM38-D2 containing only large myoepithelial cells), and to validate the role of the retinoic acid receptors (RARs) in each cell-type compartment. MATERIALS AND METHODS: We studied the expression and functionality of the RARs in LM38 cell lines. We analyzed cell growth and cell cycle distribution, apoptosis, the activity of proteases, motility properties, and expression of the molecules involved in these pathways. We also evaluated tumor growth and dissemination in vivo under retinoid treatment. RESULTS: LM38 cell lines expressed most retinoic receptor isotypes that were functional. However, only the bi-cellular LM38-LP cells responded to retinoids by increasing RARβ2 and CRBP1 expression. The growth of LM38 cell sublines was inhibited by retinoids, first by inducing arrest in MEP cells, then apoptosis in LEP cells. Retinoids induced inhibitory effects on motility, invasiveness, and activity of proteolytic enzymes, mainly in the LM38-LP cell line. In in-vivo assays with the LM38-LP cell line, RA treatment impaired both primary tumor growth and lung metastases dissemination. CCONCLUSION: These in-vivo and in-vitro results show that to achieve maximum effects of RA on tumor progression both the LEP and MEP cell compartments have to be present, suggesting that the interaction between the LEP and MEP cells is crucial to full activation of the RARs. Fil: Todaro, Laura Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina Fil: Veloso, María José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina Fil: Campodónico, Paola Bernadette. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina Fil: Puricelli, Lydia Ines. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina Fil: Farias, Eduardo Francisco. Mount Sinai School of Medicine; Estados Unidos Fil: Bal, Elisa Dora. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina |
Databáze: | OpenAIRE |
Externí odkaz: |